During the past decade, Obesity Institute, Geisinger Clinic conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Obesity Institute, Geisinger Clinic" are "Genetic Obesity" (1 trials), "Obesity" (1 trials), "Obesity Associated With Defects in Leptin-melanocortin Pathway" (1 trials) and "Obesity Due to Melanocortin 4 Receptor Deficiency" (1 trials). Many other conditions were trialed in "Obesity Institute, Geisinger Clinic" in a lesser frequency.

Most popular intervention types in "Obesity Institute, Geisinger Clinic" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Setmelanotide" (2 trials). Other intervention names were less common.

The vast majority of trials in "Obesity Institute, Geisinger Clinic" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Obesity Institute, Geisinger Clinic". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 1 completed trials in Obesity Institute, Geisinger Clinic, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Obesity Institute, Geisinger Clinic, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".